Rich nations snap up Covid vaccine stocks in global race for jab

Rich nations representing a fraction of the global population have already bought up over half the promised Covid-19 vaccine stocks, a study showed, as US President Donald Trump pledged to begin inoculating Americans within weeks. Big pharma is racing to produce an effective jab to counter a virus that has now killed more than 935,000 people around the world.

Rich nations snap up Covid vaccine stocks in global race for jab
Rich nations representing a fraction of the global population have already bought up over half the promised Covid-19 vaccine stocks, a study showed, as US President Donald Trump pledged to begin inoculating Americans within weeks. Big pharma is racing to produce an effective jab to counter a virus that has now killed more than 935,000 people around the world.